VPS13A
Overview
VPS13A (Vacuolar Protein Sorting 13 Homolog A) is a large cytoplasmic protein encoded by the gene located at chromosome 9q21.13. The protein contains 3,507 amino acids and belongs to the VPS13 family of lipid transport proteins, which are highly conserved across eukaryotes. VPS13A is primarily recognized as the causative gene for choreoacanthocytosis (ChAc), a rare autosomal recessive neurological disorder characterized by progressive movement disorder and red blood cell abnormalities. The discovery of VPS13A mutations in ChAc patients established this protein as a critical regulator of cellular lipid homeostasis and membrane dynamics, particularly in the nervous system.
Function/Biology
VPS13A functions as a lipid transport protein mediating inter-organellar lipid transfer between the endoplasmic reticulum (ER), mitochondria, and other membrane compartments. The protein contains characteristic structural domains including a N-terminal prolactin domain, a central region with high-order repeats, and a C-terminal region rich in pleckstrin homology (PH) domains. These domains enable VPS13A to interact with lipid bilayers and facilitate the transport of phospholipids, particularly phosphatidylserine, between distinct cellular compartments.
...VPS13A
Overview
VPS13A (Vacuolar Protein Sorting 13 Homolog A) is a large cytoplasmic protein encoded by the gene located at chromosome 9q21.13. The protein contains 3,507 amino acids and belongs to the VPS13 family of lipid transport proteins, which are highly conserved across eukaryotes. VPS13A is primarily recognized as the causative gene for choreoacanthocytosis (ChAc), a rare autosomal recessive neurological disorder characterized by progressive movement disorder and red blood cell abnormalities. The discovery of VPS13A mutations in ChAc patients established this protein as a critical regulator of cellular lipid homeostasis and membrane dynamics, particularly in the nervous system.
Function/Biology
VPS13A functions as a lipid transport protein mediating inter-organellar lipid transfer between the endoplasmic reticulum (ER), mitochondria, and other membrane compartments. The protein contains characteristic structural domains including a N-terminal prolactin domain, a central region with high-order repeats, and a C-terminal region rich in pleckstrin homology (PH) domains. These domains enable VPS13A to interact with lipid bilayers and facilitate the transport of phospholipids, particularly phosphatidylserine, between distinct cellular compartments.
VPS13A localizes primarily to ER-mitochondrial contact sites, specialized membrane regions where the ER closely apposed to mitochondrial membranes. At these sites, VPS13A acts as a tether protein and lipid transporter, mediating the transfer of lipids that are essential for maintaining membrane integrity, energy production, and cellular signaling. The protein interacts with components of the ER-mitochondrial encounter structure (ERMES) and maintains calcium homeostasis between these organelles. Additionally, VPS13A participates in autophagy regulation and the clearance of damaged mitochondria through mitophagy.
Role in Neurodegeneration
Mutations in VPS13A cause choreoacanthocytosis, which presents with progressive motor dysfunction including chorea (involuntary jerking movements), dystonia, parkinsonism, and cognitive decline. The neurodegeneration associated with VPS13A deficiency reflects the particular vulnerability of neurons to disrupted lipid homeostasis and mitochondrial dysfunction. Neurons maintain extremely long axons requiring substantial ATP production and precise mitochondrial positioning, making them exceptionally sensitive to defects in lipid transport and mitochondrial-ER communication.
Recent evidence suggests that VPS13A dysfunction contributes to broader neurodegenerative pathways. VPS13A loss impairs autophagy and mitophagy efficiency, leading to accumulation of damaged mitochondria and proteotoxic stress. The disrupted lipid landscape resulting from VPS13A mutations alters membrane composition, affecting neurotransmitter function, axonal transport, and synaptic plasticity. Furthermore, impaired ER-mitochondrial communication dysregulates calcium signaling, a critical second messenger in neurons, leading to excitotoxicity and neuronal death.
Molecular Mechanisms
VPS13A mutations in choreoacanthocytosis patients include nonsense mutations, frameshift deletions, and missense changes that typically result in truncated or non-functional proteins. Loss of VPS13A function impairs phosphatidylserine transfer from the ER to mitochondria, disrupting the mitochondrial lipid composition necessary for optimal oxidative phosphorylation. This defect increases mitochondrial reactive oxygen species (ROS) production and compromises cellular energy metabolism.
VPS13A deficiency also impairs autophagosome-lysosome fusion and selective autophagy pathways. Neurons accumulate polyubiquitinated protein aggregates and dysfunctional organelles, triggering ER stress and activating the unfolded protein response. The dysregulation of these quality control mechanisms leads to proteotoxic accumulation reminiscent of other neurodegenerative diseases. Additionally, VPS13A loss disrupts blood-brain barrier integrity in some disease models, suggesting broader systemic consequences beyond neuronal cell autonomy.
Clinical/Research Significance
Choreoacanthocytosis caused by VPS13A mutations typically manifests in the second to fourth decade of life with progressive motor decline, behavioral changes, and cognitive impairment. The disease is invariably progressive and fatal, with limited symptomatic treatments available. Understanding VPS13A function has illuminated fundamental mechanisms of organellar communication and lipid transport relevant to multiple neurodegenerative conditions.
Recent research demonstrates that VPS13A dysfunction shares common pathogenic features with other lipid transport disorders and idiopathic neurodegeneration, suggesting that manipulating lipid homeostasis and ER-mitochondrial contacts may represent therapeutic targets. VPS13A studies have established the importance of lipid transfer proteins in neuronal homeostasis, opening new research avenues into related disorders.
- VPS13B, VPS13C, VPS13D: Related lipid transport proteins with distinct tissue distributions and roles in Cohen syndrome and other lipid storage disorders
- ERMES Complex: ER-mitochondrial encounter structure components that functionally interact with VPS13A
- Choreoacanthocytosis: Primary human disease associated with VPS13